The Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
White House Moves to Challenge State AI Laws
White House orders review of state AI laws, pushes for a national framework; agencies may withhold funds over conflicting rules.
Read moreACR Chair Takes Part in IAEA Radiation Protection Conference
ACR Chair Alan Matsumoto, MD, joined global leaders at IAEA conference on radiation protection in medicine.
Read moreElevance Health Defends Policy
ACR signed the AMA letter, co-authored a joint letter with ACEP and ASA, and met with Elevance urging fair contracts for patient benefit.
Read more